Literature DB >> 12186862

Characterization of an osteoblast-specific enhancer element in the CBFA1 gene.

Adriana Zambotti1, Huda Makhluf, Jianhe Shen, Patricia Ducy.   

Abstract

Cbfa1 is a critical regulator of cell differentiation expressed only in the osteochondrogenic lineage. To define the molecular basis of this cell-specific expression we analyzed the murine Cbfa1 promoter. Here we show that the first 976 bp of this promoter are specifically active in osteoblastic cells. Within this region DNase I footprinting delineated a 40-bp area (CE1) protected differently by nuclear extracts from osteoblastic cells and from non-osteoblastic cells. When multimerized, CE1 conferred an osteoblast-specific activity to a heterologous promoter in DNA transfection experiments; this enhancing ability was conserved between mouse, rat, and human CE1 present in the respective Cbfa1 promoters. CE1 site-specific mutagenesis determined that it binds NF1- and AP1-like activities. Further analyses revealed that the NF1 site acts as a repressor in non-osteoblastic cells due to the binding of NF1-A, a NF1 isoform not expressed in osteoblastic cells. In contrast, the AP1 site mediates an osteoblast-specific activation caused by the preferential binding of FosB to CE1 in osteoblastic cells. In summary, this study identified an osteoblast-specific enhancer in the Cbfa1 promoter whose activity is achieved by the combination of an inhibitory and an activatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186862     DOI: 10.1074/jbc.M204271200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Identification of USF2 as a key regulator of Runx2 expression in mouse pluripotent mesenchymal D1 cells.

Authors:  Chihuei Wang; Grace Lee; Wayne Hsu; Ching-Hua Yeh; Mei-Ling Ho; Gwo-Jaw Wang
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

2.  Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).

Authors:  Ying Zhang; Mohammad Q Hassan; Rong-Lin Xie; John R Hawse; Thomas C Spelsberg; Martin Montecino; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gary S Stein
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

3.  Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.

Authors:  Laura A Pérez-Casellas; Xiaoying Wang; Kristy D Howard; Mark W Rehage; Donna D Strong; Thomas A Linkhart
Journal:  Biochim Biophys Acta       Date:  2008-09-10

4.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

5.  Genomic occupancy of HLH, AP1 and Runx2 motifs within a nuclease sensitive site of the Runx2 gene.

Authors:  Hayk Hovhannisyan; Ying Zhang; Mohammad Q Hassan; Hai Wu; Carlotta Glackin; Jane B Lian; Janet L Stein; Martin Montecino; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

Review 6.  Mechanisms of bone development and repair.

Authors:  Ankit Salhotra; Harsh N Shah; Benjamin Levi; Michael T Longaker
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-08       Impact factor: 94.444

7.  Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone.

Authors:  Yoshifumi Takahata; Takeshi Takarada; Eiichi Hinoi; Yukari Nakamura; Hiroyuki Fujita; Yukio Yoneda
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

8.  Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.

Authors:  Sonia D'Souza; Davide del Prete; Shunqian Jin; Quanhong Sun; Alissa J Huston; Flavia Esteve Kostov; Benedicte Sammut; Chang-Sook Hong; Judith L Anderson; Kenneth D Patrene; Shibing Yu; Chinavenmeni S Velu; Guozhi Xiao; H Leighton Grimes; G David Roodman; Deborah L Galson
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

9.  The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.

Authors:  Mario Galindo; Jitesh Pratap; Daniel W Young; Hayk Hovhannisyan; Hee-Jeong Im; Je-Yong Choi; Jane B Lian; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

Review 10.  Runx2, an inducer of osteoblast and chondrocyte differentiation.

Authors:  Toshihisa Komori
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.